RHBC
ESRX

R.H. Bluestein & Co’s Express Scripts Holding Company ESRX Stock Holding History

R.H. Bluestein & Co’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,000
Closed -$345K – 341
2018
Q1 		$345K Hold
5,000
– – 0.02% 218
2017
Q4 		$373K Buy
+5,000
New +$320K 0.02% 206
2014
Q2 		– Sell
-3,225
Closed -$242K – 395
2014
Q1 		$242K Buy
3,225
+305
+10% +$22.8K 0.02% 307
2013
Q4 		$205K Sell
2,920
-4,425
-60% -$289K 0.01% 331
2013
Q3 		$454K Sell
7,345
-14,275
-66% -$923K 0.03% 197
2013
Q2 		$1.33M Buy
+21,620
New +$1.3M 0.12% 75

Other funds holding ESRX

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

R.H. Bluestein & Co's ESRX Position: Q2 2018 in Review

R.H. Bluestein & Co sold out of Express Scripts Holding Company (ESRX) in Q2 2018, closing a stake of 5,000 shares — an estimated $345K sold.

R.H. Bluestein & Co first reported a position in ESRX in Q2 2013 and held it in 6 quarters. The position peaked at $1.33M in Q2 2013. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q2 2018.

  • R.H. Bluestein & Co reported no remaining Express Scripts Holding Company position as of Q2 2018 after selling out during the quarter.
  • R.H. Bluestein & Co sold 5,000 Express Scripts Holding Company shares in Q2 2018, an estimated $345K.
  • R.H. Bluestein & Co first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 6 quarters.
  • R.H. Bluestein & Co's Express Scripts Holding Company position peaked at $1.33M in Q2 2013.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2018.

Based on R.H. Bluestein & Co's 13F filing for Q2 2018, filed 10 Aug 2018.